Skip to content
IBEX

IBEX Ltd

IBEX Ltd Q3 FY2025 earnings call

May 8, 2025 · fiscal period ended 2025-03

EPS · actual vs est

$0.82 / $0.73Beat +11.7%

Revenue · actual vs est

$140.7M / $132.7MBeat +6.0%
Ask about this call

Summary

Generated 2025-05-08

Management highlights

  • Record revenue of $140.7 million, up 11% from the prior year quarter, with adjusted EBITDA of $19.4 million at a margin of 13.8% and expanded gross margin by 50 basis points.
  • Achieved a strategic milestone with entry into the India market for a leading healthcare client.
  • Won 4 key new logo opportunities in the quarter, totaling 12 for the year; significant win with a top-tier global e-commerce company providing content moderation and expanding to global English customer support.
  • Land and expand strategy in Q3 saw strong growth in top 25 and top 5 clients.
  • Wave iX AI solutions had 75 opportunities in the pipeline and 9 deployments expected in Q4 FY 2025; offshore regions grew 19% year over year; digital and omnichannel revenue grew 16% year over year.
View in transcript ↓

Segment performance

Third quarter revenue was $140.7 million, an 11% increase from $126.8 million in the prior year quarter. Revenue growth was driven by vertical growth in health tech (20%), travel, transportation, and logistics (19%), and retail and e-commerce (15%), partially offset by a 12% decline in the fintech vertical. Offshore revenues now comprise 51% of total revenue (up from 48% prior year), contributing to a 50 basis point gross margin improvement to 31.8%. Digital and omnichannel delivery represented 81% of total revenue (up from 78% prior year) and grew 16% year over year.

View in transcript ↓

Guidance

  • Raised full-year 2025 revenue guidance to $540-$545 million (previously $525-$535 million).
  • Raised adjusted EBITDA guidance to $68-$70 million (previously $68-$69 million).
  • Capital expenditures expected to remain in the range of $15 million to $20 million.
  • Launched a new $15 million share repurchase program.
View in transcript ↓

Risks

  • Matters discussed include forward-looking statements subject to various risks, uncertainties, and other factors that could cause actual results to differ materially from those expected. For a detailed description of risk factors, review the annual report on Form 10-K filed with the U.S. Securities and Exchange Commission in September 2024.
View in transcript ↓

Q&A highlights

Q: Comment on Q4 sequential trends and future trends A: Bob Dechant and Taylor Greenwald discuss that the sequential decline from Q2 to Q3 will be muted, with a small decline from Q3 to Q4 expected, but momentum continues. They note structural changes in the business and continued market share gains drive this.

Q: Year-over-year margin decline A: Bob Dechant explains that while there was a margin decline in the quarter due to investments in India, the business grew gross margin by 50 basis points year over year from high-margin services. He highlights that AI solutions are expected to be higher margin and position the business for growth.

Q: AI revenue uplift timeline and impact on existing contracts A: Bob Dechant states that AI deployments are moving from pilots to production, starting to generate revenue and margin expansion in Q4 FY 2025 and continuing into FY 2026. Wins have a two-quarter effect of piloting and then moving to full-scale production, with AI automate and AI translate solutions being accretive to revenue.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$0.82$0.73+11.7%
Revenue$140.7M$132.7M+6.0%

Transcript

May 8, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.